Department of Obstetrics and Gynecology, Lishui People's Hospital, Lishui, China.
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):322-328. doi: 10.26355/eurrev_201801_14175.
Ovarian cancer is one of the leading causes of cancer-related death in women, but treatment remained unsatisfactory. Studies have shown that lncRNA colon cancer-associated transcript 1 (CCAT1) plays an important regulatory role in different cancers, but its role in ovarian cancer remained largely unclear.
Quantitative Real-time polymerase chain reaction (qRT-PCR) was applied to detect the expression of lncRNA CCAT1 in ovarian cancer and adjacent tissue, and analysis was applied to explore the relationship between expression and clinical characteristic. After lncRNA CCAT1 suppression, Cell Counting Kit-8 (CCK8) and wound-healing assay were used to detect the proliferation and metastasis ability of ovarian cancer, respectively.
qRT-PCR showed that lncRNA CCAT1 was highly expressed in ovarian cancer tissue, compared with adjacent tissue. Moreover, we found that the expression of lncRNA CCAT1 was closely related to prognosis, tumor size, and lymph node metastasis. We also found that lncRNA CCAT1 could sponge miR-1290 in ovarian cancer.
In this study, we found that lncRNA CCAT1 could sponge miR-1290 in ovarian cancer, and was closely related to prognosis, proliferation, and metastasis.
卵巢癌是导致女性癌症相关死亡的主要原因之一,但治疗效果仍不尽人意。研究表明,长链非编码 RNA 结肠癌相关转录本 1(CCAT1)在不同癌症中发挥着重要的调节作用,但它在卵巢癌中的作用在很大程度上仍不清楚。
采用实时定量聚合酶链反应(qRT-PCR)检测卵巢癌及相邻组织中长链非编码 RNA CCAT1 的表达,并进行分析探讨表达与临床特征的关系。抑制 lncRNA CCAT1 后,使用细胞计数试剂盒-8(CCK8)和划痕愈合实验分别检测卵巢癌细胞的增殖和迁移能力。
qRT-PCR 结果显示,lncRNA CCAT1 在卵巢癌组织中的表达明显高于相邻组织。此外,我们发现 lncRNA CCAT1 的表达与预后、肿瘤大小和淋巴结转移密切相关。我们还发现 lncRNA CCAT1 可以在卵巢癌中海绵吸附 miR-1290。
本研究发现 lncRNA CCAT1 可以在卵巢癌中海绵吸附 miR-1290,与预后、增殖和转移密切相关。